Starpharma Director Boosts Stake with On-Market Purchase

Starpharma Holdings Limited (AU:SPL) has released an update.

In a notable on-market transaction, Dr. Russell Basser, a director at Starpharma Holdings Limited, has significantly increased his stake in the company by acquiring 200,000 ordinary shares at $0.093 each, amounting to a total consideration of $18,600. This purchase escalated his total direct holdings to 271,428 ordinary shares, reflecting a vote of confidence in the firm’s prospects.

For further insights into AU:SPL stock, check out TipRanks’ Stock Analysis page.